Company intelligence / Profile preview

Syntezza Bioscience

Jerusalem, Jerusalem District, Israelsyntezza.com ↗

Ownership: Private
Employees: ~20
Development stage: Commercial

Overview

Syntezza Bioscience provides advanced molecular biology products and sequencing services to academic, government, hospital, HMO, pharmaceutical, agricultural, environmental, biotechnological and medical diagnostic sectors in Israel. The company offers custom synthesis of DNA/RNA/peptides/mRNA/CRISPR reagents as well as NGS sequencing services. All offerings are strictly for research use only—not intended or warranted for clinical diagnostic or therapeutic applications.

Modalities: DNA oligonucleotidesRNA oligonucleotidesGenesPeptidesmRNA-based productsCRISPR reagents and tools
Industry: Drug Discovery Services

Partnerships

IDT – Integrated DNA TechnologiesMGIGrispTrilinkTransomicMacrogen Europe

Beyond the preview

Go deeper on Syntezza Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntezza Bioscience.

Explore the full profile